The trial will enroll about 6,000 volunteers, ages 5 and up, at as many as 50 worldwide sites where Lyme disease is a problem, including the U.S.
Author: Karen Weintraub, USA TODAY
After repeating early COVID mistakes, US now has the world’s biggest monkeypox outbreak
No one knows full extent of outbreak after delays with testing, data gathering and vaccine rollout allowed monkeypox to spread in US
Inside America’s obesity epidemic: How America’s weight (and weight loss) aren’t so simple
A deep look at how America’s weight has been changing in recent years, including advances in treatments and the scientific understanding of obesity.
New drugs and surgery can deliver major weight loss. But they come at a cost.
As the scientific understanding of weight loss deepens, new treatments are getting better but most are expensive and require a life-long commitment.
What we eat matters. Researchers are still searching for the ‘best’ diet.
Research shows ultra-processed foods can lead to weight gain. What to eat instead?
Obesity was long considered a personal failing. Science shows it’s not.
Faced with reams of scientific evidence, the medical community has begun to stop blaming patients for not losing excess pounds.
Armed with vaccines, boosters and antiviral, Biden should fare well with COVID, doctors say
Doctors agree that President Joe Biden’s COVID vaccination status and effective treatments suggest he will have a mild disease course.
‘Watershed moment’: Doctors finding new hope in treatments for deadly pancreatic cancer
Pancreatic cancer treatments are advancing and doctors have hope for a breakthrough, even as it’s poised to become the second deadliest tumor type.
‘Too busy to die’: Brain cancer patient and his mom save lives by pushing care in new ways
Jace Ward had 1 goal when he died of a brain tumor a year ago: to make the path easier for others. A year later, his mother still pursues that dream.
FDA advisory panel votes to also target omicron with fall COVID vaccine boosters
FDA advisory panel votes 19-2 to support boosters that target both omicron and the original version of the SARS-CoV-2 virus.